Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms

Vaccine-mediated prevention of primary HIV-1 infection at the heterosexual mucosal portal of entry may be facilitated by highly optimised formulations or drug delivery devices for intravaginal (i.vag) immunization. Previously we described hydroxyethylcellulose (HEC)-based rheologically structured ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Donnelly, Louise, Curran, Rhonda M., Tregoning, John S., McKay, Paul F., Cole, Tom, Morrow, Ryan J., Kett, Vicky L., Andrews, Gavin P., Woolfson, A. David, Malcolm, R. Karl, Shattock, Robin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120965/
https://www.ncbi.nlm.nih.gov/pubmed/21514349
http://dx.doi.org/10.1016/j.vaccine.2011.04.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120965/
https://www.ncbi.nlm.nih.gov/pubmed/21514349
http://dx.doi.org/10.1016/j.vaccine.2011.04.023

Ejemplares similares